Azadeh Nasrazadani

Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience

Seth A. Wander, Hyo S. Han, Mark L. Zangardi et al. · Journal of the National Comprehensive Cancer Network · 2021 · 85 citations

Medicine, Oncology, Pharmacology +16

Hotspot <i>ESR1</i> Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

Zheqi Li, Yang Wu, Megan E. Yates et al. · Cancer Research · 2022 · 85 citations · Full text

Medicine, Cancer Biology, Oncology +17

Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer

Steffi Oesterreich, Azadeh Nasrazadani, Jian Zou et al. · JNCI Journal of the National Cancer Institute · 2022 · 80 citations · Full text

Medicine, Cancer Biology, Oncology +13

Jnk2 Effects on Tumor Development, Genetic Instability and Replicative Stress in an Oncogene-Driven Mouse Mammary Tumor Model

Peila Chen, Jamye F. O’Neal, Nancy D. Ebelt et al. · PLoS ONE · 2010 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +16

c-Jun N-terminal Kinase 2 Regulates Multiple Receptor Tyrosine Kinase Pathways in Mouse Mammary Tumor Growth and Metastasis

Azadeh Nasrazadani, Carla L. Van Den Berg · Genes & Cancer · 2011 · 26 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17